Evripidis Gavathiotis
Nessuna posizione attualmente
Profilo
Evripidis Gavathiotis is the founder of Bakx Therapeutics, Inc. (founded in 2020) and Stelexis Therapeutics LLC (founded in 2017).
Precedenti posizioni note di Evripidis Gavathiotis
Società | Posizione | Fine |
---|---|---|
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics, Inc. develops novel cancer therapeutics. The company is based in DE. The American company was founded by Evripidis Gavathiotis, Loren David Walensky, Sree Kant. Sree Kant has been the CEO of the company since 2020. | Fondatore | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Health Technology |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics, Inc. develops novel cancer therapeutics. The company is based in DE. The American company was founded by Evripidis Gavathiotis, Loren David Walensky, Sree Kant. Sree Kant has been the CEO of the company since 2020. | Health Technology |
- Borsa valori
- Insiders
- Evripidis Gavathiotis